Global Anatomic Pathology Market
The global Anatomic Pathology Market was valued at USD 35100 million in 2020 which expected to reach USD 49100 million by 2027 at a CAGR 7.0% from 2020-2027.
Anatomic pathology is a medical speciality that deals with the identification of various diseases using microscopic, macroscopic, biochemical, and molecular examination of organs and tissues, as well as immunological domains. Anatomical pathology and clinical pathology are both practiced by medical experts.
Market Drivers
Cancer and other target diseases are prevalent. According to the World Population Ageing 2020 report, the global population aged 65 and up was 727 million in 2020 and is expected to double to 1.5 billion by 2050. Because the elderly are more vulnerable to numerous diseases, this demographic trend is predicted to result in a considerable increase in the prevalence of several chronic diseases, including cancer, worldwide. Cancer incidence is highest in developed nations; yet, cancer mortality is higher in developing regions due to a lack of access to treatment facilities and the late identification of cancer in numerous people.
Know more about this report: request for sample pages
Market Restraints
The market's need is being hampered by a lack of uniformity. Government regulations and laws have a detrimental impact on the growth of the Anatomic Pathology Market.
Impact of COVID-19
The COVID-19 epidemic has had an influence on the diagnostics sector in general, as well as the anatomic pathology market in particular. Despite the availability of emergency and outpatient services in hospitals, the number of patient visits to hospitals has decreased dramatically in recent months.
Cancer patients have emerged as one of the pandemic's most severely afflicted patient groups. COVID-19 has had a significant influence on the number of patients whom is screened, diagnosed, and treated for cancer. Due to the rising number of COVID-19 patients being admitted to hospitals, several hospitals and departments, including cancer clinics, have been re-profiled to treat COVID-19 patients.
Market Segmentation
The Global Anatomic Pathology Market is segmented into Product & Services, End-use. By Product & Services such as Consumables, Instruments, Services. Further, market is segmented into By End-use such as Hospitals, Research Laboratories, Diagnostic Laboratories, Others.
Regional Analysis
Global Anatomic Pathology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America has the largest market share. The anatomic pathology market in North America is growing due to factors such as rising chronic illness prevalence, rising healthcare spending, high-quality infrastructure for hospitals and clinical laboratories, and the presence of significant market players in the region.
Key Players
Various key players are listed in this report such as Danaher Corporation; PHC Holdings Corporation; Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; F. Hoffmann-La Roche AG; Agilent Technologies, Inc.; Cardinal Health; Sakura Finetek USA, Inc.; NeoGenomics Laboratories, Inc.; BioGenex;
Market Taxonomy
By Product & Services
By End-use
By Region
Key Questions Addressed by the Report
Global Anatomic Pathology Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Anatomic Pathology Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Anatomic Pathology Market, By Product & Services
5.1 Y-o-Y Growth Comparison, By Product & Services
5.2 Global Anatomic Pathology Market Share Analysis, By Product & Services
5.3 Global Anatomic Pathology Market Size and Forecast, By Product & Services
5.3.1 Consumables
5.3.2 Instruments
5.3.3 Services
6 Global Anatomic Pathology Market, By End-use
6.1 Y-o-Y Growth Comparison, By End-use
6.2 Global Anatomic Pathology Market Share Analysis, By End-use
6.3 Global Anatomic Pathology Market Size and Forecast, By End-use
6.3.1 Hospitals
6.3.2 Research Laboratories
6.3.3 Diagnostic Laboratories
6.3.4 Others
7 Global Anatomic Pathology Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Anatomic Pathology Market Share Analysis, By Application
7.3 Global Anatomic Pathology Market Size and Forecast, By Application
7.3.1 Disease Diagnosis
7.3.2. Drug Discovery and Development
7.3.4. Others
8 Global Anatomic Pathology Market, By Region
8.1 Global Anatomic Pathology Market Share Analysis, By Region
8.2 Global Anatomic Pathology Market Share Analysis, By Region
8.3 Global Anatomic Pathology Market Size and Forecast, By Region
9 North America Anatomic Pathology Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Anatomic Pathology Market Share Analysis, By Product & Services
9.3 North America Anatomic Pathology Market Size and Forecast, By End-use
9.4 North America Anatomic Pathology Market Size and Forecast, By Application
9.6 North America Anatomic Pathology Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Anatomic Pathology Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Anatomic Pathology Market Share Analysis, By Product & Services
10.3 Europe Anatomic Pathology Market Size and Forecast, By End-use
10.4 Europe Anatomic Pathology Market Size and Forecast, By Application
10.6 Europe Anatomic Pathology Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Anatomic Pathology Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Anatomic Pathology Market Share Analysis, By Product & Services
11.3 Asia Pacific Anatomic Pathology Market Size and Forecast, By End-use
11.4 Asia Pacific Anatomic Pathology Market Size and Forecast, By Application
11.6 Asia Pacific Anatomic Pathology Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Anatomic Pathology Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Anatomic Pathology Market Share Analysis, By Product & Services
12.3 Latin America Anatomic Pathology Market Size and Forecast, By End-use
12.4 Latin America Anatomic Pathology Market Size and Forecast, By Application
12.6 Latin America Anatomic Pathology Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Anatomic Pathology Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Anatomic Pathology Market Share Analysis, By Product & Services
13.3 Middle East Anatomic Pathology Market Size and Forecast, By End-use
13.4 Middle East Anatomic Pathology Market Size and Forecast, By Application
13.6 Middle East Anatomic Pathology Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Danaher Corporation
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. PHC Holdings Corporation
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Quest Diagnostics Incorporated
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Laboratory Corporation of America Holdings
15.4.1 Overview
15.4.2 Product & Servicess
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 F. Hoffmann-La Roche AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Agilent Technologies, Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Cardinal Health
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Sakura Finetek USA, Inc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 NeoGenomics Laboratories, Inc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.10 BioGenex
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies